Personalized management of hepatocellular carcinoma based on molecular information: future prospects.
作者信息
Goossens Nicolas, Hoshida Yujin
机构信息
Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. ; Division of Gastroenterology and Hepatology, Geneva University Hospital, Geneva, Switzerland.
Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
出版信息
Clin Liver Dis (Hoboken). 2015 Jun 1;5(6):132-135. doi: 10.1002/cld.483.
Abstract
摘要
相似文献
1
Personalized management of hepatocellular carcinoma based on molecular information: future prospects.基于分子信息的肝细胞癌个性化管理：未来展望
Clin Liver Dis (Hoboken). 2015 Jun 1;5(6):132-135. doi: 10.1002/cld.483.
2
Current and future challenges in the surgical treatment of hepatocellular carcinoma: a review.肝细胞癌外科治疗的当前及未来挑战：综述
Int Surg. 2014 Nov-Dec;99(6):779-86. doi: 10.9738/INTSURG-D-13-00122.1.
3
Time for paradigm change in management of hepatocellular carcinoma: is a personalized approach on the horizon?肝细胞癌管理中的范式转变时机：个性化方法即将出现？
Per Med. 2016 Sep;13(5):455-467. doi: 10.2217/pme-2016-0013. Epub 2016 Jul 27.
4
Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects.正电子发射断层扫描在肝细胞癌中的应用：现状与展望。
World J Gastroenterol. 2019 Aug 28;25(32):4682-4695. doi: 10.3748/wjg.v25.i32.4682.
5
Primary hepatocellular carcinoma. Present state of the disease and prospects for the future.原发性肝细胞癌。疾病现状与未来展望。
Cancer Chemother Pharmacol. 1982;8(2):231-5. doi: 10.1007/BF00255489.
6
Personalized therapy in hepatocellular carcinoma: Molecular markers of prognosis and therapeutic response.肝细胞癌的个性化治疗：预后和治疗反应的分子标志物
Surg Oncol. 2017 Jun;26(2):138-145. doi: 10.1016/j.suronc.2017.01.009. Epub 2017 Feb 21.
7
Hepatocellular carcinoma: Present and future.肝细胞癌：现状与未来。
Med Clin (Barc). 2018 May 23;150(10):390-397. doi: 10.1016/j.medcli.2017.08.010. Epub 2017 Oct 31.
8
Hepatocellular carcinoma: present status and future prospects.肝细胞癌：现状与未来展望
J Hepatol. 2003;38 Suppl 1:S136-49. doi: 10.1016/s0168-8278(02)00432-4.
9
Hepatocellular carcinoma: molecular and genomic guideline for the clinician.肝细胞癌：临床医生的分子和基因组指南。
Clin Liver Dis. 2011 May;15(2):307-21, vii-x. doi: 10.1016/j.cld.2011.03.010.
10
Current status and future prospects of chemotherapy for advanced hepatocellular carcinoma.晚期肝细胞癌化疗的现状与未来展望
Clin J Gastroenterol. 2016 Aug;9(4):184-90. doi: 10.1007/s12328-016-0670-7. Epub 2016 Jul 11.
引用本文的文献
1
Inhibition of pMAPK14 Overcomes Resistance to Sorafenib in Hepatoma Cells with Hepatitis B Virus.抑制pMAPK14可克服乙型肝炎病毒阳性肝癌细胞对索拉非尼的耐药性。
Transl Oncol. 2018 Apr;11(2):511-517. doi: 10.1016/j.tranon.2018.02.015. Epub 2018 Mar 7.
2
Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort.亚太岛屿队列中与甲胎蛋白水平相关的肝细胞癌的临床和分子亚分类
Hepatoma Res. 2018;4. doi: 10.20517/2394-5079.2017.46. Epub 2018 Jan 12.
本文引用的文献
1
A new initiative on precision medicine.一项关于精准医学的新倡议。
N Engl J Med. 2015 Feb 26;372(9):793-5. doi: 10.1056/NEJMp1500523. Epub 2015 Jan 30.
2
Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies.非酒精性脂肪性肝病相关肝细胞癌的临床特征：一项人体研究综述
Clin J Gastroenterol. 2015 Feb;8(1):1-9. doi: 10.1007/s12328-014-0548-5. Epub 2015 Jan 10.
3
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.丙型肝炎病毒诱导肝细胞癌的发病机制与预防
J Hepatol. 2014 Nov;61(1 Suppl):S79-90. doi: 10.1016/j.jhep.2014.07.010. Epub 2014 Nov 3.
4
Treating Immune-tolerant Hepatitis B.治疗免疫耐受期乙型肝炎
J Viral Hepat. 2015 Feb;22(2):77-84. doi: 10.1111/jvh.12370. Epub 2014 Nov 25.
5
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.跨种族肝细胞癌基因组的突变特征。
Nat Genet. 2014 Dec;46(12):1267-73. doi: 10.1038/ng.3126. Epub 2014 Nov 2.
6
Liver cancer biopsy--back to the future?!肝癌活检——回归未来？！
Hepatology. 2015 Feb;61(2):431-3. doi: 10.1002/hep.27545. Epub 2015 Jan 5.
7
A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration.一种预测临床恶化的丙型肝炎相关早期肝硬化的基因组和临床预后指数。
Gut. 2015 Aug;64(8):1296-302. doi: 10.1136/gutjnl-2014-307862. Epub 2014 Aug 20.
8
Liver cancer: time to evolve trial design after everolimus failure.肝癌：依维莫司治疗失败后，是时候改变试验设计了。
Nat Rev Clin Oncol. 2014 Sep;11(9):506-7. doi: 10.1038/nrclinonc.2014.136. Epub 2014 Aug 5.
9
Antiviral treatment of hepatitis C.丙型肝炎的抗病毒治疗。
BMJ. 2014 Jul 7;348:g3308. doi: 10.1136/bmj.g3308.
10
Risk calculators for hepatocellular carcinoma in patients affected with chronic hepatitis B in Asia.亚洲慢性乙型肝炎患者肝细胞癌风险计算器
World J Gastroenterol. 2014 May 28;20(20):6244-51. doi: 10.3748/wjg.v20.i20.6244.
Zotero 插件